B2M and chronic kidney disease: At this point, we would like to put forward a hypothesis that we think ties together many observations in both CKD and ESRD: the emergence of non-renal processes as determinants of serum β2M levels as renal function declines and the beneficial effects of HF-HD dialysis in patients with hypoalbuminemia as highlighted by reports from our group (229, 309).